Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments.
Kam
Peter C A
PC
Department of Anaesthesia and Pain Management, University of Sydney at the Royal North Shore Hospital, St Leonards, New South Wales, Australia. pkam@med.usyd.edu.au
Egan
Mark K
MK
D000818:Animals; D001792:Blood Platelets / Q000502:physiology*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass / Q000009:adverse effects; D006801:Humans; D007431:Intraoperative Complications / Q000097:blood / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000145:classification / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex